FIELD: medicine. SUBSTANCE: method involves determination of IgG 1,2,4-antibodies to lipopolysaccharide from Salmonella Minnesota R595 (Re-mutant) and E. coli 0114 by IFA-method using protein A. Ratio index between antibodies and lipopolysaccharides is measured, and damage profile in organism resistance is determined by comparison of three indices. EFFECT: enhanced precision of resistance estimation. 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EVALUATION OF ANTIENDOTOXIN IMMUNITY STATE WITH RESPECT TO GRAM-NEGATIVE BACTERIA (LPS-TEST-IFA) | 1994 |
|
RU2088936C1 |
| METHOD FOR DIAGNOSTICS OF LATENT DISEASES BASING ON SYSTEMIC ENDOTOXAMIA INDICES | 2015 |
|
RU2609763C1 |
| METHOD OF ASSAY OF PHARMACEUTICAL PREPARATION PYROGENIC PROPERTY (PYROTEST) | 1996 |
|
RU2093825C1 |
| METHOD FOR DETERMINING HUMORAL IMMUNITY LEVEL WITH RESPECT TO CONDITIONALLY PATHOGENIC BACTERIA BY SIMULTANEOUSLY DETECTING IGG ANTIBODIES | 2002 |
|
RU2213972C1 |
| METHOD FOR EVALUATING ENDOTOXINEMIA IN CHILDREN SUFFERING FROM ATOPIC BRONCHIAL ASTHMA | 2000 |
|
RU2177616C1 |
| METHOD FOR DETERMINING ANTIOXIDATION ACTIVITY OF ANTIOXIDANT PREPARATIONS | 1999 |
|
RU2160898C1 |
| METHOD OF ESTIMATING GENERAL OXIDANT STATUS OF ORGANISM | 2009 |
|
RU2407450C1 |
| AFFINITY-MATURED CRIG VERSIONS | 2009 |
|
RU2553517C2 |
| REAGENT FOR EVALUATING CROSS-CROSSLINKED FIBRIN SPLITTING PRODUCT AND METHOD OF SUCH EVALUATION | 2017 |
|
RU2742279C2 |
| VACCINE AGAINST CAMPYLOBACTERIOSIS | 2014 |
|
RU2671473C2 |
